Anti-PD1-induced collagenous colitis in a melanoma patient

Melanoma Research

Volumn 26, Issue 3, 2016, Pages 308-311

  Baroudjian, Barouyr ^a   Lourenco, Nelson ^a   Pagès, Cécile ^a   Chami, Ichrak ^a   Maillet, Marianne ^a   Bertheau, Philippe ^a   Bagot, Martine ^a   Gornet, Jean Marc ^a   Lebbé, Céleste ^a   Allez, Matthieu ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

collagenous colitis; diarrhea; drug toxicity; melanoma; pembrolizumab

Indexed keywords

BUDESONIDE; COLESTYRAMINE; IPILIMUMAB; LEVOTHYROXINE; PEMBROLIZUMAB; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN KINASE INHIBITOR;

AGED; ANHIDROSIS; ARTICLE; BRAIN METASTASIS; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CASE REPORT; COLLAGENOUS COLITIS; COLON MUCOSA; DIARRHEA; DRUG EFFICACY; DRUG TREATMENT FAILURE; ENOPHTHALMOS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HORNER SYNDROME; HUMAN; HYPOKALEMIA; HYPOPHYSITIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; MELANOMA; MIOSIS; MULTIPLE CYCLE TREATMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCOAST TUMOR; PERITONEUM METASTASIS; PRIORITY JOURNAL; PTOSIS; SIDE EFFECT; SKIN METASTASIS; STEREOTACTIC RADIATION THERAPY; WEIGHT REDUCTION; WHOLE BODY SCINTISCANNING; ANTAGONISTS AND INHIBITORS; COMPLICATION; IMMUNOTHERAPY; PATHOLOGY; PROCEDURES; SKIN TUMOR;

AGED; COLITIS, COLLAGENOUS; FEMALE; HUMANS; IMMUNOTHERAPY; MELANOMA; PROGRAMMED CELL DEATH 1 RECEPTOR; PROTEIN KINASE INHIBITORS; SKIN NEOPLASMS;

EID: 84961218650     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0000000000000252     Document Type: Article

References (15)

1. Mitchell KA, Kluger H, Sznol M, Hartman DJ. Ipilimumab-induced perforating colitis. J Clin Gastroenterol 2013; 47:781-785.
2. Lord JD, Hackman RC, Moklebust A, Thompson JA, Higano CS, Chielens D, et al. Refractory colitis following anti-CTLA4 antibody therapy: analysis of mucosal FOXP3 + T cells. Dig Dis Sci 2010; 55:1396-1405.
3. Beck KE, Blansfield JA, Tran KQ, Feldman AL, Hughes MS, Royal RE, et al. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol 2006; 24:2283-2289.
4. Minor DR, Chin K, Kashani-Sabet M. Infliximab in the treatment of anti-CTLA4 antibody (ipilimumab) induced immune-related colitis. Cancer Biother Radiopharm 2009; 24:321-325.
5. Bertrand A, Kostine M, Barnetche T, Truchetet ME, Schaeverbeke T. Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis. BMC Med 2015; 13:211.
6. Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 2015; 372:320-330.
7. Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, et al. KEYNOTE-006 Investigators. Pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med 2015; 372:2521-2532.
8. Pardi DS, Smyrk TC, Tremaine WJ, Sandborn WJ. Microscopic colitis: a review. Am J Gastroenterol 2002; 97:794-802.
9. Schneider S, Rampal A, Hebuterne X, Rampal P. Microscopic colitis. Gastroenterol Clin Biol 1998; 22:431-441.
10. Tong J, Zheng Q, Zhang C, Lo R, Shen J, Ran Z, et al. Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and metaanalysis. Am J Gastroenterol 2015; 110:265-276.
11. Baert F, Schmit A, D'Haens G, Dedeurwaerdere F, Louis E, Cabooter M, et al. Belgian IBD Research Group, Codali Brussels. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 2002; 122:20-25.
12. Fine KD, Lee EL. Efficiency of open-label bismuth subsalicylate for the treatment of microscopic colitis. Gastroenterology 1998; 114:29-36.
13. Pardi DS, Loftus EV Jr, Tremaine WJ, Sandborn WJ. Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterology 2001; 120:1483-1484.
14. Pola S, Fahmy M, Evans E, Tipps A, Sandborn WJ. Successful use of infliximab in the treatment of corticosteroid dependent collagenous colitis. Am J Gastroenterol 2013; 108:857-858.
15. Guagnozzi D, Lucendo AJ. Advances in knowledge on microscopic colitis: from bench to bedside. Rev Esp Enferm Dig 2015; 107:98-108.